|

REGN9933 Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: amrecibart

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Regeneron Pharmaceuticals2

Indications

Dothan, Alabama2 trials

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

SEC Clinical Research

Phase 2
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

SEC Clinical Research

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.